查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552625

北美合法大麻市场规模、份额和趋势分析报告：按来源、按衍生物、按种植、按最终用途、按地区、按细分市场、预测，2024-2030 年

North America Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End Use (Medical, Recreational, Industrial), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

北美合法大麻市场成长与趋势

Grand View Research, Inc.最新报告显示，到2030年，北美合法大麻市场规模预计将达到821.8亿美元，2024年至2030年复合年增长率为11.9%。

因素包括大麻合法化、人们对大麻衍生产品的治疗功效的认识提高以及大麻用于医疗和娱乐目的的增加。大麻衍生产品广泛用于治疗患有癌症、帕金森氏症、阿兹海默症和关节炎等慢性疾病的患者。

此外，越来越多的临床试验显示利用大麻治疗各种疾病的正面作用。例如，Sage Journal 于 2023 年 5 月发表的一项临床研究发现，据报道，非吸入医用大麻或大麻素对慢性疼痛患者的疼痛缓解、睡眠品质和身体功能的改善微乎其微。因此，这种积极的结果将增加该地区对大麻药物的需求。

将人工智慧 (AI) 和机器人技术融入大麻种植中，透过提供先进的作物管理和预测能力来提高效率并标准化产量。该技术结合了环境条件和土壤品质等各种指标的资料分析，以预测潜在问题，优化耕作方法，并有效管理资源，降低成本和减少体力劳动。例如，加拿大的 PURPLEFARM 于 2024 年 6 月与人工智慧公司 Neatleaf 合作，利用 Neatleaf Spyder 系统来优化和自动化其大麻种植过程。

市场的主要企业包括 Canopy Growth Corporation 、 Charlotte's Web , Inc . 、 Aurora Cannabis 、 Tilray Brands 、 The Cronos Group 、 Jazz Pharmaceuticals , Inc . 、 Sundial Growers 和 Medipharm Labs 。这些公司正在采取重大策略措施来扩大其业务足迹和市场地位。例如，2022年11月，Charlotte's Web Inc.与加拿大大麻包装商品公司Tilray建立了策略伙伴关係。这种合作关係使 Charlotte 能够在加拿大生产和销售 CBD 大麻萃取物。

北美合法大麻市场报告亮点

  • 从来源来看，由于医用大麻合法化程度不断提高以及大麻产品的采用率不断提高，预计大麻细分市场将在 2023 年占据市场主导地位，并在预测期内增长最快。
  • 从衍生性商品来看，由于 CBD 在各种医疗应用中的使用不断增加，以及人们对 CBD 在治疗各种医疗状况方面的有效性的认识不断增加，CBD 细分市场在 2023 年占据了最大的市场占有率。
  • 以栽培领域来看，由于投资增加、技术进步和创新、有利的政府倡议和法律规范，室内领域在 2023 年占据最大的市场占有率。
  • 按最终用途划分，受年轻人越来越多地采用大麻电子烟、大麻休閒用途增加以及预测期内最高增长率的推动，休閒细分市场将在 2023 年占据市场主导地位，预计将快速增长。复合年增长率。
  • 2023年，由于医用大麻优惠的报销政策以及消费者对大麻使用的积极态度，美国在北美合法大麻市场中占据最大的市场占有率。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章北美合法大麻市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 助剂市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 北美合法大麻：市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析
  • 法律规范

第 4 章：2018-2030 年北美合法大麻市场細項分析（按来源）（百万美元）

  • 定义和范围
  • 2023年及2030年供应源市场占有率分析
  • 细分仪表板
  • 2018-2030 年北美合法大麻市场（依来源）
  • 大麻
    • 2018-2030 年大麻市场估计与预测
    • 花
    • 油和酊剂
  • 麻
    • 2018-2030 年大麻市场估计与预测
    • 大麻CBD
    • 工业大麻

第 5 章：北美合法大麻市场細項分析（按衍生性商品），2018-2030 年（百万美元）

  • 定义和范围
  • 2023 年及 2030 年衍生性商品市场占有率分析
  • 细分仪表板
  • 北美合法大麻市场（按衍生性商品），2018-2030
  • CBD
    • 2018-2030年CBD市场估计与预测
  • THC
    • 2018-2030 年 THC 市场估计与预测
  • 其他的
    • 2018-2030 年其他市场估计与预测

第 6 章：北美合法大麻市场細項分析（按种植情况），2018-2030 年（百万美元）

  • 定义和范围
  • 2023年及2030年种植市场占有率分析
  • 细分仪表板
  • 北美合法大麻市场（按种植情况），2018-2030 年
  • 室内栽培
    • 2018-2030年室内种植市场估算与预测
  • 温室栽培
    • 2018-2030年温室栽培市场估价及预测
  • 户外栽培
    • 2018-2030年户外种植市场估计与预测

第 7 章：2018-2030 年北美合法大麻市场細項分析（按最终用途）（百万美元）

  • 定义和范围
  • 2023 年及 2030 年最终用途市场占有率分析
  • 细分仪表板
  • 北美合法大麻市场（按最终用途），2018-2030 年
  • 医疗用途
    • 2018-2030年医疗市场收益估算与预测
    • 癌症
    • 慢性疼痛
    • 忧郁症和焦虑
    • 关节炎
    • 糖尿病
    • 青光眼
    • 偏头痛
    • 癫痫
    • 多发性硬化症
    • 爱滋病
    • 肌萎缩侧索硬化症
    • 阿兹海默症
    • 创伤后压力症候群（PTSD）
    • 帕金森氏症
    • 妥瑞症
    • 其他的
  • 休閒用途
    • 2018-2030 年休閒用途市场收益估算与预测
  • 工业用途
    • 2018-2030年工业应用市场收益估算与预测

第 8 章：2018-2030 年北美合法大麻市场按地区、产品、材料和最终用途分析（百万美元）

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 区域市场简介
  • 北美合法大麻市场占有率（按地区，2023年和2030年）：
  • 北美洲
    • 北美合法大麻市场，2018-2030
    • 美国
    • 加拿大

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司简介
    • Canopy Growth Corporation
    • Charlotte's Web, Inc.
    • Aurora Cannabis Inc.
    • Tilray Brands
    • The Cronos Group
    • Jazz Pharmaceuticals, Inc.
    • Sundial Growers
    • Medipharm Labs
    • NuLeaf Naturals, LLC
    • Irwin Naturals
Product Code: GVR-4-68039-828-0

North America Legal Cannabis Market Growth & Trends:

The North America legal cannabis market size is expected to reach USD 82.18 billion by 2030, registering a CAGR of 11.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as legalization of cannabis, growing awareness about the therapeutic benefits of cannabis-based products, and rising use of cannabis for medical & recreational purposes. Cannabis-derived products are widely used for treating patients suffering from chronic conditions, such as cancer, Parkinson's disease, Alzheimer's disease, and arthritis.

Moreover, the rising number of clinical trials signifies the positive effects of utilizing cannabis for treating various medical conditions. For instance, a clinical study published by Sage Journal in May 2023 reported that non-inhaled medical cannabis or cannabinoids result in a very small to small improvement in pain relief, sleep quality, and physical functioning in patients suffering from chronic pain. Thus, such positive results increase the demand for cannabis-based medicines in this region.

Incorporating artificial intelligence (AI) and robotics into cannabis cultivation enhances efficiency and standardizes yields by offering advanced crop management and prediction capabilities. This technology reduces costs and the need for manual labor by incorporating data analysis from various indicators, such as environmental conditions and soil quality, forecasting potential problems, optimizing growing practices, and managing resources effectively. For instance, in June 2024, PURPLEFARM,a Canadian company, partnered with Neatleaf, an AI company, to optimize and automate its cannabis cultivation processes using the Neatleaf Spyder system.

Some of the key players in the market are Canopy Growth Corporation, Charlotte's Web, Inc., Aurora Cannabis, Tilray Brands, The Cronos Group, Jazz Pharmaceuticals, Inc., Sundial Growers, and Medipharm Labs. These companies adopt key strategic initiatives to expand their business footprint and market position. For instance, in November 2022, Charlotte's Web Inc. entered a strategic alliance with Tilray, a Canada-based cannabis packaged goods company. This alliance allows Charlotte to manufacture and distribute its CBD hemp extract offerings in Canada.

North America Legal Cannabis Market Report Highlights:

  • By source, the marijuana segment dominated the market in 2023 and is anticipated to witness the fastest growth over the forecast period owing to the growing adoption of marijuana products along with the increasing legalization of medical marijuana
  • By derivatives, the CBD segment held the largest market share in 2023, owing to the rising use of CBD for various medical applications and awareness regarding its effectiveness in treating various medical conditions
  • By cultivation, the indoor segment held the largest market share in 2023 due to rising investments, technological advancements & innovations, favorable government initiatives, and regulatory framework
  • By end use, the recreational segment dominated the market in 2023 and is anticipated to grow at the fastest CAGR over the forecast period due to the growing adoption of cannabis vape pens among youths and increased use of cannabis for recreational purposes
  • In 2023, the U.S. accounted for the largest market share in the North America legal cannabis market, owing to favorable reimbursement policies for medical cannabis and the positive attitude of consumers towards cannabis utilization

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Source outlook
    • 2.2.2. Derivatives outlook
    • 2.2.3. Cultivation outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. North America Legal Cannabis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. North America Legal Cannabis: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Framework

Chapter 4. North America Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. North America Legal Cannabis market, by Source, 2018 to 2030
  • 4.5. Marijuana
    • 4.5.1. Marijuana market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Flowers
      • 4.5.2.1. Flowers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Oil and Tinctures
      • 4.5.3.1. Oil and Tinctures market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Hemp
    • 4.6.1. Hemp market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.2. Hemp CBD
      • 4.6.2.1. Hemp CBD market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.3. Industrial Hemp
      • 4.6.3.1. Industrial Hemp market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. North America Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Derivatives Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. North America Legal Cannabis market, by Derivatives, 2018 to 2030
  • 5.5. CBD
    • 5.5.1. CBD market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. THC
    • 5.6.1. THC market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Other derivatives
    • 5.7.1. Other derivatives market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. North America Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Cultivation Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. North America Legal Cannabis market, by Cultivation, 2018 to 2030
  • 6.5. Indoor Cultivation
    • 6.5.1. Indoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Greenhouse Cultivation
    • 6.6.1. Greenhouse Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Outdoor Cultivation
    • 6.7.1. Outdoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. North America Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2023 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Global North America Legal Cannabis Market, by End Use, 2018 to 2030
  • 7.5. Medical Use
    • 7.5.1. Medical Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Cancer
      • 7.5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Chronic Pain
      • 7.5.3.1. Chronic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Depression and Anxiety
      • 7.5.4.1. Depression and Anxiety Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Arthritis
      • 7.5.5.1. Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Diabetes
      • 7.5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Glaucoma
      • 7.5.7.1. Glaucoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Migraine
      • 7.5.8.1. Migraine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Epilepsy
      • 7.5.9.1. Epilepsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Multiple Sclerosis
      • 7.5.10.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. AIDS
      • 7.5.11.1. AIDS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Amyotrophic Lateral Sclerosis
      • 7.5.12.1. Amyotrophic Lateral Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Alzheimer's
      • 7.5.13.1. Alzheimer's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Post Traumatic Stress Disorder (PTSD)
      • 7.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.15. Parkinson's
      • 7.5.15.1. Parkinson's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.16. Tourette's
      • 7.5.16.1. Tourette's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.17. Others
      • 7.5.17.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Recreational Use
    • 7.6.1. Recreational Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Industrial Use
    • 7.7.1. Industrial Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America Legal Cannabis Market Segment Analysis, By Region, By Product, By Material, By End Use, 2018- 2030 (USD Million)

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Regional Market Snapshot
  • 8.4. North America Legal Cannabis Market Share by Region, 2023 & 2030:
  • 8.5. North America
    • 8.5.1. North America Legal Cannabis market, 2018 - 2030 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. U.S. Legal Cannabis market, 2018 - 2030 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Canada Legal Cannabis market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Profiles
    • 9.3.1. Canopy Growth Corporation
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. Charlotte's Web, Inc.
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Aurora Cannabis Inc.
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Tilray Brands
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. The Cronos Group
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Jazz Pharmaceuticals, Inc.
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Sundial Growers
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Medipharm Labs
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. NuLeaf Naturals, LLC
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Irwin Naturals
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America legal cannabis market, by source, 2018 - 2030 (USD Million)
  • Table 4 North America legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
  • Table 5 North America legal cannabis market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America North America legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
  • Table 7 North America North America legal cannabis market, by region, 2018 - 2030 (USD Million)
  • Table 8 U.S legal cannabis market, by source, 2018 - 2030 (USD Million)
  • Table 9 U.S legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
  • Table 10 U.S legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
  • Table 11 U.S legal cannabis market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Canada legal cannabis market, by source, 2018 - 2030 (USD Million)
  • Table 13 Canada legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
  • Table 14 Canada legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
  • Table 15 Canada legal cannabis market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 North America legal cannabis market: outlook
  • Fig. 9 North America legal cannabis competitive insights
  • Fig. 10 Ancillary market outlook
  • Fig. 11 North America legal cannabis market driver impact
  • Fig. 12 North America legal cannabis market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 North America legal cannabis market: Source movement analysis
  • Fig. 16 North America legal cannabis market: Source outlook and key takeaways
  • Fig. 17 Marijuana market estimates and forecast, 2018 - 2030
  • Fig. 18 Flowers market estimates and forecast, 2018 - 2030
  • Fig. 19 Oil and Tinctures market estimates and forecast, 2018 - 2030
  • Fig. 20 Hemp market estimates and forecast, 2018 - 2030
  • Fig. 21 Hemp CBD market estimates and forecast, 2018 - 2030
  • Fig. 22 Industrial Hemp market estimates and forecast, 2018 - 2030
  • Fig. 23 North America legal cannabis market: Derivatives movement analysis
  • Fig. 24 North America legal cannabis market: Derivatives outlook and key takeaways
  • Fig. 25 CBD market estimates and forecasts, 2018 - 2030
  • Fig. 26 THC market estimates and forecasts, 2018 - 2030
  • Fig. 27 Other derivatives market estimates and forecasts, 2018 - 2030
  • Fig. 28 North America legal cannabis market: Cultivation movement analysis
  • Fig. 29 North America legal cannabis market: Cultivation outlook and key takeaways
  • Fig. 30 Indoor Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 31 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 32 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 33 North America legal cannabis market: End Use movement analysis
  • Fig. 34 North America legal cannabis market: End Use outlook and key takeaways
  • Fig. 35 Medical Use market estimates and forecasts, 2018 - 2030
  • Fig. 36 Chronic Pain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Depression and Anxiety market estimates and forecasts, 2018 - 2030
  • Fig. 38 Post-Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
  • Fig. 39 Arthritis market estimates and forecasts, 2018 - 2030
  • Fig. 40 Migraines market estimates and forecasts, 2018 - 2030
  • Fig. 41 Cancer market estimates and forecasts, 2018 - 2030
  • Fig. 42 Epilepsy market estimates and forecasts, 2018 - 2030
  • Fig. 43 Alzheimer's market estimates and forecasts, 2018 - 2030
  • Fig. 44 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
  • Fig. 45 Diabetes market estimates and forecasts, 2018 - 2030
  • Fig. 46 Tourette's market estimates and forecasts, 2018 - 2030
  • Fig. 47 Parkinson's market estimates and forecasts, 2018 - 2030
  • Fig. 48 AIDS market estimates and forecasts, 2018 - 2030
  • Fig. 49 Glaucoma market estimates and forecasts, 2018 - 2030
  • Fig. 50 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
  • Fig. 51 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 52 Others market estimates and forecasts, 2018 - 2030
  • Fig. 53 Recreational Use market estimates and forecasts, 2018 - 2030
  • Fig. 54 Industrial Use market estimates and forecasts, 2018 - 2030
  • Fig. 55 North America legal cannabis market: Regional movement analysis
  • Fig. 56 North America legal cannabis market: Regional outlook and key takeaways
  • Fig. 57 North America North America legal cannabis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 U.S. legal cannabis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Canada legal cannabis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Key company categorization
  • Fig. 64 Heat map analysis, 2022 - 2023